Acta Psychiatr Scand

1. ERCIS M, Miola A, Ortiz-Orendain J, Pazdernik VK, et al
   Three Distinct Pathways to First Episode Mania and Psychosis: Latent Class Analysis of Antecedent Psychopathology.
   Acta Psychiatr Scand. 2025;152:278-289.
   

   >> Share

   
   

   
   Am J Psychiatry

2. HOWES OD, Bukala BR, Chen EYH, Correll CU, et al
   Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.
   Am J Psychiatry. 2025 Oct 8:appiajp20241040. doi: 10.1176/appi.ajp.20241040.
   

   >> Share

   
   

   
   Biol Psychiatry

3. MA Y, Girdhar K, Hoffman GE, Fullard JF, et al
   Sex differences in brain cell-type specific chromatin accessibility in schizophrenia.
   Biol Psychiatry. 2025 Oct 8:S0006-3223(25)01517.
   

   >> Share

   
   

   
   Compr Psychiatry

4. HE Y, Ng SM, Ran MS, Wang C, et al
   Beyond criticism, hostility, and emotional overinvolvement: Development and psychometric validation of the Comprehensive Expressed Emotion Scale (CEES) in schizophrenia.
   Compr Psychiatry. 2025;143:152638.
   

   >> Share

   
   
5. HAO J, Bruggeman R, Veling W, Alizadeh BZ, et al
   The power of youth: Long-term differential effects of developmental functioning trajectory on social functioning, quality of life and personal recovery across the schizophrenia spectrum.
   Compr Psychiatry. 2025;143:152637.
   

   >> Share

   
   

   
   Mol Psychiatry

6. WALTHER S, Maderthaner L, Chapellier V, von Kanel S, et al
   Gesture deficits in psychosis and the combination of group psychotherapy and transcranial magnetic stimulation: A randomized clinical trial.
   Mol Psychiatry. 2025 Oct 8. doi: 10.1038/s41380-025-03303.
   

   >> Share

   
   
7. MARTINEZ-SADURNI L, Barrera-Conde M, Robledo P, Veza-Estevez E, et al
   Differential effect of cannabis use and antipsychotic medication on extracellular free-water in the brain of individuals with early psychosis and controls.
   Mol Psychiatry. 2025 Oct 7. doi: 10.1038/s41380-025-03287.
   

   >> Share

   
   

   
   Neuropsychopharmacology

8. O'BRIEN KJ, Huque ZM, Pike MR, Smith EC, et al
   Synergistic pathways to psychosis: understanding developmental risk and resilience factors.
   Neuropsychopharmacology. 2025 Oct 10. doi: 10.1038/s41386-025-02261.
   

   >> Share

   
   
9. CHATTERJEE S, Soria M, Norville ZC, Thompson KR, et al
   Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M(1) and M(4) receptors.
   Neuropsychopharmacology. 2025 Oct 4. doi: 10.1038/s41386-025-02256.
   

   >> Share

   
   

   
   PLoS One

10. DONATH VM, Ries ES, Mariegaard L, Kristensen TD, et al
    Alleviating negative symptoms in schizophrenia using a virtual reality-based therapy targeting social reward learning (ENGAGE): Protocol for a randomised, controlled, assessor-blind pilot study.
    PLoS One. 2025;20:e0331632.
    

    >> Share

    
    

    
    Psychiatry Res

11. MONTI P, Iodice S, Capuzzi E, Borroni E, et al
    Short-term exposure to particulate matter and apparent temperature is associated with schizophrenia severity in Italy.
    Psychiatry Res. 2025;353:116735.
    

    >> Share

    
    
12. XUE J, Zhai Z, Li X, Zhu Y, et al
    Deep transcranial magnetic stimulation over the anterior cingulate cortex in treatment-resistant schizophrenia: A pilot double-blind, randomized controlled trial.
    Psychiatry Res. 2025;353:116756.
    

    >> Share

    
    

    
    Psychol Med

13. ZHANG Y, Wang H, Cai M, Wang W, et al
    From risk to chronicity: genetic and neuroimaging insights into the evolving patterns of spontaneous brain activity in schizophrenia.
    Psychol Med. 2025;55:e306.
    

    >> Share

    
    

    
    Schizophr Res

14. STANICA AM, Remiszewski N, Shen C, Sponheim SR, et al
    Subcortical brain abnormalities and cognitive function in individuals with psychosis and their unaffected relatives: A normative modeling approach.
    Schizophr Res. 2025;285:255-264.
    

    >> Share

    
    
15. ALTINOK DCA, Fritze S, Volkmer S, Brandt GA, et al
    Emotional maltreatment shapes the relationship between psychosocial functioning and hippocampal structure in schizophrenia spectrum disorders.
    Schizophr Res. 2025;285:242-254.
    

    >> Share

    
    
16. CROWLEY P, Healy J, McNamara N, Twomey R, et al
    Duration of active psychosis: A scoping review of definition, measurement, and relationship with outcomes.
    Schizophr Res. 2025;285:232-241.
    

    >> Share

    
    
17. KAMPHUIS S, Arias-Magnasco A, Gangadin S, Begemann M, et al
    Association between the exposome score for schizophrenia and functioning in remitted first-episode psychosis: results from the HAMLETT study.
    Schizophr Res. 2025;285:223-231.
    

    >> Share

    
    
18. XIA W, Hau C, Burns J, Ryan S, et al
    Smartphone intervention apps for schizophrenia: A review of the academic literature and app stores.
    Schizophr Res. 2025;285:204-214.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share